fashion -WSS

fashion

author：Wikipedia 2025-09-07 00:17:07 - browse：44898

Adam's take main illustration — Molly Ferguson/STAT

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome.

What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December, Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.

If blarcamesine fails to achieve the pre-determined goals of clinical trials, the thinking apparently goes, then just make a post-hoc change to the study goals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： FDA cancer chief on how to get things done: ‘Don’t tell anybody'

hotspot

WSS

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Carbon Health diabetes program, a test of data

Ventyx halts psoriasis drug development after lackluster trial results

How to fix the rural physician shortage in the U.S.

Study suggests Covid rebound is far more common with Paxlovid than without

FDA reorg will put new emphasis on investigations, sources say

explore

fashion

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Can medical device makers keep up in the race to treat obesity?

Activists slam private health insurers over coverage restrictions

White House drug czar issues call for 'recovery

Trump demands the U.S. pay no more for drugs than other countries … again

Medicare’s new pay boost for primary care is angering specialists

Affirmative action in medical school literally saved lives

Can medical device makers keep up in the race to treat obesity?

Sports medicine is finally prioritizing gender equality

Type 2 diabetes prevention programs work at large scale: study

leisure time

Medicare’s new pay boost for primary care is angering specialists

White House drug czar issues call for 'recovery

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

After decades in use, heart stents finally beat placebo

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Medicare’s new pay boost for primary care is angering specialists

leisure time

entertainment

hotspot

leisure time